Artesunate-Loaded and Near-Infrared Dye-Conjugated Albumin Nanoparticles as High-Efficiency Tumor-Targeted Photo-Chemo Theranostic Agent
- 151 Downloads
Herein, a tumor-targeted multifunctional theranostic agent was synthetized using a facile method, combining four clinically approved materials: artesunate (Arte), human serum albumin (HSA), folic acid (FA), and indocyanine green (ICG). The obtained nanocomposites (FA-IHA NPs) showed an excellent photo- and physiological stability. The ICG in the FA-IHA NPs was used not only for near infrared (NIR) fluorescence imaging, but also for photothermal and photodynamic (PTT-PDT) therapy under a single NIR irradiation. In addition, the NIR irradiation (808 nm, 1 W/cm2) could trigger Arte release that showed enhanced chemotherapeutic effect. Through fluorescence imaging, the cell uptake and tumor accumulation of FA-IHA NPs were observed in vitro and in vivo, analyzed by confocal microscopy and NIR fluorescence imaging in tumor xenograft mice. Based on the diagnostic results, FA-IHA NPs at 24 h post injection and combined with NIR irradiation (808 nm, 1 W/cm2) could efficiently suppress tumor growth through a photo-chemo combination therapy, with no tumor recurrence in vitro and in vivo. The obtained results suggested that FA-IHA NPs are promising photo-chemo theranostic agents for future clinical translation.
KeywordsTheranostic agent Artesunate Fluorescence imaging Reactive oxygen species Indocyanine green
Human serum albumin
During these recent decades, imaging-guided photo-chemo therapy (IGPC) attracted great interest by many researchers, since it is a promising strategy to realize a personalized tumor therapy [1, 2]. IGPC allows the exact location of the tumor and traces the drug in vivo, guaranteeing an effective therapy and reducing side effects [3, 4]. To be effective, IGPC should have the following characteristics: (i) a multifunctional theranostic agent with both imaging and therapeutic functions is needed; (ii) the theranostic agent should be biocompatible, stable, and specific against the tumor [5, 6, 7, 8]. The imaging diagnosis modality in the IGPC usually includes magnetic resonance imaging, photoacoustic imaging, and fluorescence imaging [9, 10, 11, 12, 13, 14]. Due to the high sensitivity, favorable temporal resolution, and high signal to background ratio, fluorescence imaging was usually applied for basic research and in clinical practice [15, 16].
The photo-chemo therapy methods mainly include photothermal therapy (PTT), photodynamic therapy (PDT), and chemotherapy. Since the near infrared (NIR) irradiation is the same, PTT and PDT function can be integrated into one, making possible a selective and efficient destruction of the tumor through a laser beam. However, it was reported that photothermal and photodynamic (PTT-PDT) therapy has often the limitation of an incomplete tumor suppression, which can potentially generate a tumor relapse [17, 18, 19]. Chemotherapy, an extensively used treatment method against cancer, can effectively kill tumor cells through systemic administration, although the toxicity to nearby normal cells due to its non-specificity limits its application [20, 21, 22]. Therefore, the IGPC combination could be a great strategy to overcome the above limitations.
With the development of the nanomedicine, IGPC theranostic agents have been developed, including indocyanine green (ICG), metal-based nanoparticles, carbon nanomaterials, and polymer nanomaterials [23, 24, 25, 26, 27]. Among them, ICG was approved by FDA, and its use in clinical practice is reported to detect cardiac output, liver function, blood flow, and ophthalmic angiography [28, 29]. In addition, ICG has high-absorption efficiency at NIR region, thus inducing high PTT-PDT effect under a single NIR irradiation . However, the following drawbacks such as instability in aqueous solution, rapid clearance in the body, the tendency to self-bleaching, and lack of targeting, severely hinder its extensive application [31, 32]. To overcome these limitations, free ICG molecules are usually carried by vehicles including micelles, polymer nanoparticles, and self-assembled protein nanostructures, to form nanocomposites [33, 34]. Although related works are available, more biocompatible and novel ICG based nanocomposites are still demanded for in vivo imaging and phototherapy.
In this work, we reported a targeted IGPC agent that covalently conjugated folic acid (FA) and ICG with human serum albumin (HSA) nanoparticles which also encapsulated the anticancer drug artesunate (Arte) (FA-IHA NPs). FA has been reported to link nanoparticles to increase their cell uptake efficiency via receptor-mediated endocytosis . HSA is an endogenous protein. Because of its good biocompatibility, non-toxic, and non-immunogenicity, HSA has become one of the most exciting carriers to deliver insoluble anticancer drugs [12, 17, 31]. Arte, a natural drug extracted from Artemisia annua, has been proved a significant efficacy in the treatment of various cancers, such as liver cancer, lung cancer, and breast cancer . The prepared FA-IHA NPs consisted of these four clinical approved materials and showed great biocompatibility and stability. As a multifunctional theranostic nanocomposite, ICG was applied as a NIR fluorescence imaging agent and phototherapy agent due to its PTT-PDT properties. Arte was highly loaded into the NPs and released by NIR irradiation for chemotherapy. Guided by the NIR imaging results, the high effect of the targeted IGPC combination was demonstrated both in vitro and in vivo. According to our results, we believe that FA-IHA NPs might be a potential versatile theranostic agent in controlled drug delivery and imaging-guided tumor-targeted combinational photo-chemo therapy.
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimidehydrochloride (EDC), N-hydroxysuccinimide (NHS), and artesunate (Arte, ≥ 99%) were obtained from Sigma-Aldrich (USA). 4′, 6′-diamidino-2-phenylindole (DAPI) and Cell Counting Kit-8 (CCK-8) were purchased from Aladdin (Shanghai, China). NH2–PEG2000–COOH and NH2–PEG2000-FA were bought from Xi’an Ruixi Biological Technology Co., Ltd. (Xi’an, China). DMEM media and phosphate buffer saline (PBS) were provided from Gibco BRL (NY, USA). Sulfo-NHS derivative of ICG (ICG-NHS) was bought from Dojindo Laboratories (Kumamoto, Japan).
Synthesis and Characterization of FA-IHA NPs
Artesunate was dissolved in DMSO and then added into 15 mL water. 10 mg HSA powder was added into the above solution and stirred slightly for 3 h at room temperature. After stirring, the mixture was processed by cross-linking with 150 μL 0.5% glutaraldehyde. In order to remove the redundant chemical reagents, the mixture was dialyzed against distilled water (MW cut off = 8,000–12,000 Da) for 1 day, resulting in a Arte-loaded HSA nanocomposites (Arte-HSA).
To activate the carboxylic groups of HSA, the chemical reagents EDC and NHS were added into the Arte-HSA solution. After that, the mixture was reacted with NH2–PEG2000-FA for 3 h at 4°С. Next, the ICG-NHS was added into the mixture under slight stirring for 30 min at room temperature. The purified FA and ICG-conjugated HSA nanoparticles (FA-ICG-HSA@Arte, FA-IHA NPs) were obtained by dialysis in the deionized water for 24 h. The amount of loaded Arte and ICG was detected by a UV-vis spectrophotometer. The loading efficiency = W1 / W2 × 100%, where W1 represents the weight of Arte or ICG in FA-IHA NPs, and W2 is the weight of Arte or ICG added.
The transmission electron microscopy (Hitachi, Tokyo, Japan) was used to detect the morphology of the samples. A Zetasizer (Zetasizer 3000; Malvern Instruments, Worcestershire, UK) was used to measure the size and zeta potential of the samples. A UV-vis spectrophotometer (UV-1601PC, Shimadzu, Kyoto, Japan) was applied to measure the absorbance spectra. The 808 nm single wavelength continuous wave laser (Beijing Laserwave Optoelectronics Technology Co. Ltd) was applied to conduct photothermal experiments, and the temperature was detected by a thermocouple thermometer (Fluke, USA).
Thermal and pH-Triggered Arte Release
To determine the thermal and pH-triggered Arte release, FA-IHA NPs (50 μg/mL) was divided into three groups: (a) pH 6.5, (b) pH 7.4, and (c) pH 6.5 with NIR irradiation (808 nm, 1 W/cm2, 1 min pulse) at selected time points during 36 h. The released amount of Arte was determined according to the UV-vis absorption of Arte at 287 nm in the supernatant.
Detection of Singlet Oxygen Production
1, 3-diphenylisobenzofuran (DPBF) was used to detect the singlet oxygen. 15 μL DPBF acetonitrile solution was added into pristine ICG or FA-IHA NPs solution (1.0 mL, 10 μg/mL) and mixed thoroughly, followed by 5 min of irradiation (808 nm, 1.0 W/cm2). The UV-vis absorption spectra were recorded at different time points, and the decrease rate of absorption at 410 nm is proportional to the singlet oxygen production.
Cell Culture and Cellular Uptake
HepG2 cells were purchased from American Type Culture Collection and in 25 cm2 cell-culture flask respectively, with DMEM culture medium by adding 1% penicillin-streptomycin and 10% fetal bovine serum (FBS). HepG2 cells were kept at 37 °C in a 5% CO2 atmosphere.
To observe cellular uptake, HepG2 cells were cultured with free ICG, IHA NPs, and FA-IHA NPs (with 0.05 mg/mL of ICG) for 6 h. After that, PBS was used to wash the treated cells for three times. The cells were then fixed with 200 μL glutaraldehyde and stained with DAPI for 10 min. The fluorescence signals of the nanoparticles in cells were detected by using a confocal laser scanning microscope (FV300, Olympus, Japan).
To further evaluate cellular uptake, a flow cytometer (FCM, BD, Franklin Lakes, NJ, USA) was applied. As described above, the free ICG-, IHA NPs-, and FA-IHA NPs-treated cells were washed three times with PBS and digested by trypsin-EDTA. The suspended cells were directly introduced to FCM to analyze the cellular uptake ratio.
Generation of Intracellular ROS
HepG2 cells were cultured in 12-well plates with a density of 2 × 105 cells per milliliter and incubated for 24 h, followed by the addition of 1 mL of various samples including (1) PBS, (2) Arte, (3) FA-HA-NPs, (4) free ICG, (5) IHA-NPs, and (6) FA-IHA NPs solution. After a further incubation for 12 h, the cells were irradiated for 5 min (808 nm, 1.0 W/cm2), followed by a treatment with DCFH-DA (5 μg/mL) for another 30 min. Finally, the cells were washed thoroughly with PBS, and the production of intracellular ROS was detected quantitatively by using a cytometer and qualitatively with a Leica-inversed fluorescence microscopy.
In Vitro Tumor Combinational Photo-Chemo Therapy
HepG2 cells were seeded in 96-well plates (2 × 104 cells per well) for 24-h incubation. Free ICG, Arte, IHA NPs, and FA-IHA NPs (with 0, 5, 10, 20, and 30 μg/mL of Arte) were added into the cells. After a 6-h incubation, the old media were discarded. The treated cells were irradiated with or without an 808 nm laser (1.0 W/cm2, 5 min) and cultured for the next 24 h. Cell viability was measured by a classic CCK-8 assay according to the protocol.
In order to further confirm the live and dead cells after NIR treatment, the treated cells were co-stained by calcein-AM/PI. HepG2 cells were pre-seeded in 35 mm plates at a density of 1 × 106 cells per plate and were treated with PBS, PBS + NIR, FA-IHA NPs, or FA-IHA NPs + NIR. After 6 h of incubation, cells were irradiated for 5 min by 808 nm laser (1 W/cm2) and cultured for the next 24 h. Cells were stained with calcein-AM/PI for 30 min, washed with PBS to remove excess dye solution, and then imaged using a confocal laser scanning microscope (calcein-AM lex = 488 nm, lem = 515 nm; PI lex = 535 nm, lem = 617 nm).
Animal Model and In Vivo Fluorescence Imaging
Balb/c nude mice were obtained from The Center of Laboratory Animal Science of Guangdong Province and used under protocols approved by Guangzhou Medical University. In order to establish HepG2 subcutaneous tumors, 1 × 106 HepG2 cells (in 100 μL PBS) were injected into the back of Balb/c nude mouse.
Tumor bearing mice (n = 5) were imaged by a commercially available IVIS Spectrum system (Caliper LifeSciences, USA) before and at 10 min, 6 h, 12 h, 24 h, and 48 h post-intravenous injection of free ICG, IHA NPs, and FA-IHA NPs.
In Vivo Tumor Combinational Photo-Chemo therapy
Tumor bearing mice were randomly divided into different groups (n = 5) and were treated by PBS, Arte, FA-IHA NPs, ICG + NIR, IHA NPs + NIR, and FA-IHA NPs + NIR (with equal free Arte dose), respectively. Five-minute NIR laser (808 nm, 1 W/cm2) was used to irradiate the tumor region at 24 h (day 0) and 48 h (day 1) post-intravenous injection of these samples. The thermal images and temperature of the irradiated mice were recorded. During the treatment, tumor size was recorded every 4 days and calculated according to the equation: volume = (tumor length) × (tumor width)2 / 2. The results were shown by the relative tumor volume which was the tumor volume divided by the initial tumor volume. After treatment, major organs including heart, liver, spleen, lungs, and kidney of those mice in PBS and FA-IHA NPs + NIR groups were harvested, fixed in 4% formalin, embedded into paraffin, stained with H&E, and recorded by a digital microscope.
Results and Discussion
Synthesis and Characterization of FA-IHA NPs
Under NIR laser irradiation (808 nm, 1 W/cm2) and pH condition, the release performance was investigated (Fig. 4b). As the contrast, without NIR irradiation, FA-IHA NPs showed 11.61% and 34.2% Arte release under pH 7.4 and pH 6.5, respectively, while under NIR irradiation for six times, FA-IHA NPs showed a total of 68.4% Arte release at pH 6.5, suggesting that NIR irradiation and acid condition could both significantly trigger Arte release from FA-IHA NPs. The NIR irradiation and acid responsive drug release were likely due to the heat-induced expansion of HSA nanoparticles, and in addition, at acidic environment, the H+ could change the surface charge of HSA that alter the hydrophilic/hydrophobic balance of the nanoparticles [37, 38].
Cell Uptake and Detection of Intracellular ROS
In Vitro Tumor Combinational Photo-Chemo therapy
In Vivo Fluorescence Imaging
In Vivo Tumor Combinational Photo-Chemo therapy
In conclusion, a multifunctional theranostic agent was prepared, covalently conjugating FA and ICG, and encapsulating Arte for imaging-guided tumor-targeted combinational photo-chemo therapy in vitro and in vivo. The prepared FA-IHA NPs showed excellent colloidal- and heat-stabilities and fluorescence property. Under NIR irradiation, FA-IHA NPs showed great photothermal effect which could trigger Arte release and produce much more ROS after NIR irradiation than free ICG that exhibited photodynamic performance. The conjugated FA facilitated a highly efficient cellular uptake and tumor accumulation in vitro and in vivo. Moreover, the highly effective anticancer efficacy of FA-IHA NPs combined active targeting thermal drug chemotherapy, such as PTT-PDT therapy, which was demonstrated in vitro and in vivo. Overall, the results obtained indicated that FA-IHA NPs might be a promising tumor-targeted system feasible for future nanomedicine applications.
Availability of Data and Materials
The conclusions made in this manuscript are based on the data (main text and figures) presented and shown in this paper.
HY, ZL, DC, and HL designed the experiment. HY, ZL, ZZ, and XL analyzed the data. HY and ZL conducted the experiments and prepared the manuscript. DC and HL revised and approved the manuscript. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
- 12.Chen J, Li X, Liu X, Yan H, Xie Z, Sheng Z, Gong X, Wang L, Liu X, Zhang P, Zheng H, Song L, Liu C (2018) Hybrid MoSe2–indocyanine green nanosheets as a highly efficient phototheranostic agent for photoacoustic imaging guided photothermal cancer therapy. Biomater Sci 6:1503–1516CrossRefGoogle Scholar
- 19.Ayala-Orozco C, Urban C, Bishnoi S, Urban A, Charron H, Mitchell T, Shea M, Nanda S, Schiff R, Halas N, Joshi A (2014) Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors. J Control Release 191:90–97CrossRefGoogle Scholar
- 25.Mashal A, Sitharaman B, Li X, Avti PK, Sahakian AV, Booske JH, Hagness SC (2010) Toward carbon-nanotube-based theranostic agents for microwave detection and treatment of breast cancer: enhanced dielectric and heating response of tissue-mimicking materials. IEEE Trans Biomed Eng 57:1831–1834CrossRefGoogle Scholar
- 35.Kim C, Lee JH, Kim SH, Sethi G, Ahn KS (2015) Artesunate suppresses tumor growth and induces apoptosis through the modulation of multiple oncogenic cascades in a chronic myeloid leukemia xenograft mouse model. Oncotarget 6:4020–4035Google Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.